XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Interim Condensed Consolidated Statements Of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Class A Common Stock [Member]
Retained Earnings
Accumulated Other Comprehensive Income/(Loss)
Total Stockholders' Equity - Dolby Laboratories, Inc.
Noncontrolling Interest
Beginning balance (in shares) at Sep. 24, 2021   100,000            
Beginning balance at Sep. 24, 2021 $ 2,604,232   $ 0   $ 2,607,909 $ (10,030) $ 2,597,979 $ 6,253
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 116,529       116,734   116,734 (205)
Other comprehensive income/(loss), net of tax (5,598)         (5,651) (5,651) 53
Distributions to noncontrolling interest (1,435)             (1,435)
Stock-based compensation expense 60,355   60,355       60,355  
Repurchase of common stock (in shares)   (2,000)            
Repurchase of common stock (120,486)   (62,696)   (57,788)   (120,486)  
Cash dividends declared and paid on common stock (50,681)       (50,681)   (50,681)  
Common stock issued under employee stock plans 35,062 $ 1 35,061       35,062  
Tax withholdings on vesting of restricted stock (32,720)     $ (32,720)     (32,720)  
Deconsolidation of subsidiary (70)       (820)   (820) 750
Ending balance (in shares) at Apr. 01, 2022   99,000            
Ending balance at Apr. 01, 2022 2,605,188   0   2,615,354 (15,681) 2,599,772 5,416
Beginning balance (in shares) at Dec. 31, 2021   100,000            
Beginning balance at Dec. 31, 2021 2,642,521   0   2,649,175 (11,521) 2,637,754 4,767
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 36,519       36,720   36,720 (201)
Other comprehensive income/(loss), net of tax (4,060)         (4,160) (4,160) 100
Stock-based compensation expense 27,699   27,699       27,699  
Repurchase of common stock (in shares)   (2,000)            
Repurchase of common stock (84,913)   (40,588)   (44,323)   (84,913)  
Cash dividends declared and paid on common stock (25,398)       (25,398)   (25,398)  
Common stock issued under employee stock plans 13,690 $ 1 13,689       13,690  
Tax withholdings on vesting of restricted stock (800)     (800)     (800)  
Deconsolidation of subsidiary (70)       (820)   (820) 750
Ending balance (in shares) at Apr. 01, 2022   99,000            
Ending balance at Apr. 01, 2022 2,605,188   0   2,615,354 (15,681) 2,599,772 5,416
Beginning balance (in shares) at Sep. 30, 2022   94,000            
Beginning balance at Sep. 30, 2022 2,251,020   0   2,297,730 (51,641) 2,246,183 4,837
Ending balance (in shares) at Dec. 30, 2022   95,000            
Ending balance at Dec. 30, 2022 2,292,525   0   2,319,358 (31,875) 2,287,578 4,947
Beginning balance (in shares) at Sep. 30, 2022   94,000            
Beginning balance at Sep. 30, 2022 2,251,020   0   2,297,730 (51,641) 2,246,183 4,837
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 175,331       175,071   175,071 260
Other comprehensive income/(loss), net of tax 24,592         24,215 24,215 377
Distributions to noncontrolling interest (266)             (266)
Stock-based compensation expense 61,067   61,067       61,067  
APIC, Share-Based Payment Arrangement, Increase for Cost Capitalized $ 671   671       671  
Repurchase of common stock (in shares) (1,311,907) (1,000)            
Repurchase of common stock $ (99,276)   (56,330)   (42,945)   (99,276)  
Cash dividends declared and paid on common stock (51,741)       (51,741)   (51,741)  
Common stock issued under employee stock plans 21,394 $ 2 21,392       21,394  
Tax withholdings on vesting of restricted stock (26,800)     (26,800)     (26,800)  
Ending balance (in shares) at Mar. 31, 2023   95,000            
Ending balance at Mar. 31, 2023 2,355,992   0   2,378,115 (27,426) 2,350,784 5,208
Beginning balance (in shares) at Dec. 30, 2022   95,000            
Beginning balance at Dec. 30, 2022 2,292,525   0   2,319,358 (31,875) 2,287,578 4,947
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 95,883       95,696   95,696 187
Other comprehensive income/(loss), net of tax 4,523         4,449 4,449 74
Stock-based compensation expense 29,827   29,827       29,827  
APIC, Share-Based Payment Arrangement, Increase for Cost Capitalized 330   330       330  
Repurchase of common stock (49,864)   (38,797)   (11,067)   (49,864)  
Cash dividends declared and paid on common stock (25,872)       (25,872)   (25,872)  
Common stock issued under employee stock plans 10,440   10,440       10,440  
Tax withholdings on vesting of restricted stock (1,800)     $ (1,800)     (1,800)  
Ending balance (in shares) at Mar. 31, 2023   95,000            
Ending balance at Mar. 31, 2023 $ 2,355,992   $ 0   $ 2,378,115 $ (27,426) $ 2,350,784 $ 5,208